Abstract
Rhinitis medicamentosa (RM) is a drug induced non-allergic rhinitis associated with prolonged use of topical nasal decongestants. This review discusses the nasal mucosa microcirculation, basic pharmacology of topical decongestants and the theories of the pathophysiology of RM. Diagnostic problems are discussed in addition to the current opinion on how to treat RM.
Similar content being viewed by others
References
Ramey J, Bailen E, Lockey R (2006) Rhinitis medicamentosa. J Investig Allergol Clin Immunol 16(3):148–155
Stride R (1967) Nasal decongestant therapy. Br J Clin Pract 21:541–548
Toohill R, Lehman R, Grossman T et al (1981) Rhinitis medicamentosa. Laryngoscope 91:1614–1621
Fleece L, Mizes J, Jolly P et al (1984) Rhinitis medicamentosa: conceptualisation, incidence and treatment. Ala J Med Sci 21:205–208
Feinberg A, Feinberg S (1971) The “nose drop nose” due to oxymetazoline and other topical vasoconstrictors. Ill Med J 140:50–52
Baldwin R (1977) Rhinitis medicamentosa (an approach to treatment). J Med Assoc State Ala 47:33–35
Silva A, Silva A, Stankiewicz A (1995) Nasal obstruction in pregnancy. Prim Care Update Ob Gyns 2:37–44. doi:10.1016/1068-607X(94)00046-8
Corboz M, Rivelli M, Varty L, Mutter J, Cartwright M, Rizzo C et al (2005) Pharmacological characterization of postjunctional alpha-adrenoceptors in human nasal mucosa. Am J Rhinol 19:495–502
Hall L, Jackson R (1968) Effects of alpha and beta-adrenergic agonists on nasal blood flow. Ann Otol Rhinol Laryngol 77:1120–1131
Corboz M, Rivelli M, Mingo G, McLeod R, Varty L, Jia Y et al (2008) Mechanism of decongestant activity of alpha 2-adrenoceptor agonists. Pulm Pharmacol Ther 21:449–454. doi:10.1016/j.pupt.2007.06.007
Passali D, Salerni L, Passali G, Passali F, Bellussi L (2006) Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use. Expert Opin Drug Saf 5(6):783–790. doi:10.1517/14740338.5.6.783
Lacroix J (1989) Adrenergic and nonadrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand Suppl 581:1–63
Elwany S, Stephanos W (1983) Rhinitis medicamentosa—an experimental histopathological and biochemical study. ORL J Otorhinolaryngol Relat Spec 45(4):187–194
Graf P (2005) Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med 4(1):21–29. doi:10.2165/00151829-200504010-00003
Richards R, Cavill R (1976) Electron microscopic study of the effect of benzalkonium chloride and edeta disodium on the cell envelope of Pseudomonas aeruginosa. J Pharm Sci 65:76–80. doi:10.1002/jps.2600650115
Graf P, Hallen H, Juto J (1995) The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol 20:224–229. doi:10.1111/j.1365-2273.1995.tb01853.x
Graf P (2007) Rhinitis medicamentosa. Clin Allergy Immunol 19:295–304
Conflicts of interest statement
I take full responsibility for the content of this paper. Ethical approval was not applicable. I have no conflicts of interests to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doshi, J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Eur Arch Otorhinolaryngol 266, 623–625 (2009). https://doi.org/10.1007/s00405-008-0896-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-008-0896-1